Clinical Trials List
2010-09-30 - 2012-08-31
Phase IV
Terminated5
ICD-10G95.81
Conus medullaris syndrome
ICD-10G95.89
Other specified diseases of spinal cord
ICD-9336.8
Other myelopathy
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- MING YAO Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- 蔡偉 Division of Hematology & Oncology
- Chien-Yuan Chen Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 余垣斌 Division of Hematology & Oncology
- 曾成槐 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- 洪英中 Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Chang Liu Division of Hematology & Oncology
- 張肇松 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
42 participants
-
Global
0 participants
